Alphabet's AI-Powered Drug Development: A Game-Changer Ahead of Earnings?
2025-02-04
MSN
As Alphabet prepares to release its earnings, experts weigh in on the company's AI-driven drug development potential. Big Technology's Alex Kantrowitz joins CNBC's Deirdre Bosa and Wealth Enhancement's Ayako Yoshioka to discuss the impact of artificial intelligence on the pharmaceutical industry and its potential to boost Alphabet's stock. With AI technology advancing rapidly, investors are watching closely to see how Alphabet's innovative approach to drug development will shape the future of healthcare. Key trends to watch include machine learning, pharmaceutical innovation, and tech industry growth.
